Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biogen Idec (NQ: BIIB ) 230.72 -3.12 (-1.33%) Streaming Delayed Price Updated: 10:35 AM EDT, Jun 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biogen Idec < Previous 1 2 3 4 5 6 7 8 9 ... 44 45 Next > Are Gene Therapy Stocks The Market's Next Big Winners? September 25, 2023 Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan September 25, 2023 From Biogen Inc. Via GlobeNewswire California Attorney General Cracks Down On Deceptive Abortion Pill Reversal Claims September 22, 2023 California Attorney General Rob Bonta has taken legal action against two anti-abortion organizations, Heartbeat International (HBI) and RealOptions Obria, for making unsupported claims about reversing... Via Benzinga (BIIB) - Analyzing Biogen's Short Interest September 20, 2023 Via Benzinga $100 Invested In Biogen 15 Years Ago Would Be Worth This Much Today September 15, 2023 Via Benzinga $1000 Invested In Biogen 15 Years Ago Would Be Worth This Much Today September 04, 2023 Via Benzinga (BIIB) - Analyzing Biogen's Short Interest September 01, 2023 Via Benzinga Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy? September 09, 2023 Buying a biotech is a good move, but it might not be enough to entice investors. Via The Motley Fool 7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth September 07, 2023 Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners. Via InvestorPlace Denali Therapeutics Breakthrough Blood-Brain Barrier Platform A Game-Changer in Neurodegenerative Diseases: Analyst September 06, 2023 B Riley Securities initiated coverage on Denali Therapeutics Inc (NASDAQ: DNLI) with a Buy rating and a Via Benzinga 3 Healthcare Stocks to Sell in September Before They Crash & Burn September 06, 2023 The prognosis for these healthcare stocks isn't optimistic so plan to sell them this month before they get worse. Via InvestorPlace Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For September 06, 2023 Longeveron (NASDAQ: LGVN), a clinical-stage biopharma developing potential treatments for age-related and life-threatening diseases, is expecting data from its phase 2a trial for its Lomecel-B™... Via Benzinga Analyst Ratings for Biogen August 29, 2023 Via Benzinga Better Buy: Biogen vs. Eli Lilly August 29, 2023 This battle of biotech giants has a clear winner. Via The Motley Fool If You Invested $100 In This Stock 15 Years Ago, You Would Have $500 Today August 14, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 September 06, 2023 Via Benzinga Biogen Appoints Jane Grogan as Head of Research September 06, 2023 From Biogen Inc. Via GlobeNewswire The 3 Best Biotech Stocks to Buy Now: September 2023 September 04, 2023 With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize. Via InvestorPlace Sage Therapeutics Cuts Workforce By 40% Following Rejection In Depression Treatment August 31, 2023 The company is now focusing on its launch in postpartum depression. Via Investor's Business Daily The 7 Most Promising Momentum Stocks to Own Now August 31, 2023 These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility. Via InvestorPlace The 3 Most Promising Pharma Stocks to Own Now August 30, 2023 A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride. Via InvestorPlace Wall Street Thinks This Tiny Biotech Company Could Soar Soon August 28, 2023 An upcoming regulatory decision could prove to be an inflection point in the biotech's life cycle. Via The Motley Fool Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock August 24, 2023 Cassava had $168.4 million of cash at the end of June after losing $28.7 million during the second quarter of 2023. SAVA stock is up 5% Via InvestorPlace Is Sage Therapeutics Stock in Trouble After Dropping 50% in a Month? August 24, 2023 The pharmaceutical company's growth prospects have taken a big hit. Via The Motley Fool BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA) August 17, 2023 From Brodsky & Smith LLC Via GlobeNewswire Why Shares of Sage Therapeutics Slumped This Week August 11, 2023 The company got bad news from the FDA and saw increased losses. Via The Motley Fool Exposures Product Safety Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around? August 10, 2023 The company's rare disease portfolio may soon get an upgrade. Via The Motley Fool With an Acquisition on the Way, Is Biogen Stock a Buy? August 09, 2023 Can the biotech finally get back in the good graces of investors? Via The Motley Fool Eli Lilly Has A Big Stake In Weight Loss And Alzheimer's Drugs; But Is The Stock A Buy? August 09, 2023 Lilly shares surged 15% in one day to a record high. Here's what you should know. Via Investor's Business Daily BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED) August 08, 2023 From Brodsky & Smith LLC Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 ... 44 45 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.